Every baby born in Texas gets two newborn screening blood tests that check for a number of rare disorders. The first test is done 24 to 48 hours after birth. The second one is done at the baby’s checkup at one to two weeks of age. Read more about the newborn screening tests.
The following list describes the 29 core conditions screened through blood spots. On May 26, 2015, Texas began reporting results for 24 secondary conditions in addition to the core conditions.
Biotinidase Deficiency (BIOT)
BIOT is an enzyme deficiency that occurs in about 1 in 60,000 U.S. newborns and can result in seizures, hearing loss, and death in severe cases. Treatment is simple and involves daily doses of biotin. (1) BIOT Fact Sheet
Congenital Adrenal Hyperplasia (CAH)
21-Hydroxylase Deficiency - CAH is caused by decreased or absent production of certain adrenal hormones. The most prevalent type is detected by newborn screening in about 1 in 9,000 Texas newborns. Early detection can prevent death in boys and girls and sex misassignment in girls. Treatment involves lifelong hormone replacement therapy. (1) CAH Fact Sheet
Congenital Hypothyroidism (CH)
Inadequate or absent production of thyroid hormone results in CH and is present in about 1 in 2,000 Texas newborns. Thyroid hormone replacement therapy begun by 1 month of age can prevent intellectual and growth disabilities.(1) CH Fact Sheet
Cystic Fibrosis (CF)
An inherited disease that affects the lungs, digestive system, and overall growth. People with CF have thickened secretions, which clog the lungs and cause breathing problems. It can also affect the pancreas and make it hard to break down and absorb food. (1) CF Fact Sheet
Galactose-1-Phosphate Uridyltransferase (GALT) Deficiency - Failure to metabolize the milk sugar galactose results in GAL and occurs in about 1 in 50,000 U.S. newborns. The classical form detected by newborn screening can lead to cataracts, liver cirrhosis, intellectual disability and/or death. Treatment is elimination of galactose from the diet usually by substituting soy for milk products. (1) GAL Fact Sheet
HCY is caused by an enzyme deficiency that blocks the metabolism of an amino acid that can lead to intellectual disability, osteoporosis and other problems if left undetected and untreated. The incidence is approximately 1 in 350,000 U.S. newborns. Treatment may involve a special restricted protein diet and supplemental medicines, including Vitamin B6. (1) HCY Fact Sheet
Maple Syrup Urine Disease (MSUD)
MSUD is a defect in the way that the body metabolizes certain amino acids and is present in about 1 in 200,000 U.S. newborns. Early detection and treatment with a special restricted protein diet can prevent death and severe intellectual disability. There is an increased risk in Mennonites. (1) MSUD Fact Sheet
Medium Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency
The most common disorder in the way the body metabolizes fatty acids is called MCAD deficiency. Undetected, it can cause sudden death. Treatment is simple and includes ensuring frequent food intake. The incidence from newborn screening is not yet known, but is thought to be approximately 1 in 15,000 U.S. newborns. (1) MCAD Fact Sheet
An enzyme defect that prevents metabolism of phenylalanine, an amino acid essential to brain development, is known as PKU and occurs in approximately 1 in every 23,000 Texas newborns. Undetected and untreated with a special restricted protein diet, PKU leads to irreversible intellectual disability. Persons of European descent are at increased risk. (1) PKU Fact Sheet
Severe Combined Immunodeficiency (SCID)
SCID is a rare, serious group of disorders involving the immune system. The immune system is composed of T and B lymphocytes or T and B cells, the white blood cells that are responsible for fighting infections caused by viruses, bacteria and fungi. Babies with SCID are not able to fight infection. They appear healthy at birth but can become sick very quickly when exposed to common illnesses. SCID is so rare that medical providers might not diagnose it until it is too late to provide lifesaving treatment. (1) SCID Fact Sheet
Sickle Cell Disease (SCD)
Includes Sickle Cell Anemia (Hb SS),
Sickle Beta Thalassemia (Hb S/Th), and
Sickle-Hemoglobin C Disease (Hb S/C).
Sickle cell anemia (Hemoglobin-SS-Disease) is the most prevalent SCD and causes clogged blood vessels resulting in severe pain and other severe health problems. Other common SCDs include Hemoglobin-SC-Disease and various thalassemias. Newborn screening detects about 1 in 2,500 Texas newborns with SCD annually. Persons of African or Mediterranean descent are at an increased risk. Early treatment with daily penicillin prevents death in the first few years of life. (3) SCD Brochure, Hb-SS Fact Sheet
Tyrosinemia Type I (TYR 1)
TYR is caused by a deficiency in the liver of one enzyme that breaks down tyrosine. If not treated, the condition causes severe liver disease and other serious health problems. Treatment consists of medication including vitamin D and nitisinone, and a special restricted protein diet. The estimated incidence is 1 case in every 100,000 live births. (1) TYR 1 Fact Sheet
Other Fatty Acid Oxidation (FAO)
Carnitine Uptake Defect (CUD),
Long-Chain Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD),
Trifunctional Protein Deficiency (TFP), and
Very-Long-Chain Acyl-Co A Dehydrogenase Deficiency (VLCAD).
Other FAO disorders may be detected through newborn screening. They are usually described in categories based on the length of the fatty acid involved. Undetected and untreated they can cause seizures, coma, and even death. Treatment may include a low fat diet, frequent food intake, supplementation with L-Carnitine (Carnitor) and medium chain triglycerides. The incidences of various FAO disorders are not known since it is only recently that early detection through newborn screening has occurred. (4) CUD Fact Sheet, LCHAD Fact Sheet, TFP Fact Sheet, VLCAD Information Sheet
Organic Acid (OA)
3-Methylcrotonyl-CoA Carboxylase Deficiency (3MCC),
Beta-Ketothiolase Deficiency (BKD),
Glutaric Acidemia Type 1 (GA1),
Hydroxymethylglutaric Aciduria (HMG),
Isovaleric Acidemia (IVA),
Methylmalonic Acidemia(MMA) (Cbl A and Cbl B forms) ( Cbl A,B),
Methylmalonic Acidemia (mutase deficiency form) (MUT),
Multiple Carboxylase Deficiency (MCD), and
Propionic Acidemia (PROP).
Organic acidemias are a group of metabolic disorders that lead to accumulation of organic acids in the blood and urine and may be detected in newborn screening through analysis of acylcarnitine profiles. Symptoms can be diminished by restricting protein in the diet and supplementation with vitamins and/or L-Carnitine. Because newborn screening for these disorders is relatively new, the degree of occurrence in newborns is not yet known. (9) 3MCC Fact Sheet, BKD Fact Sheet, GA1 Fact Sheet, HMG Fact Sheet, IVA Fact Sheet, MMA Fact Sheet, MCD Fact Sheet, PROP Fact Sheet
Urea Cycle Disorders (UCD)
Argininosuccinic Acidemia (ASA), and
A UCD is a genetic disorder caused by a deficiency of one of the enzymes responsible for removing ammonia from the blood stream. Some UCDs may be detected as a part of newborn screening. They are characterized by seizures, poor muscle tone, respiratory distress, and coma, and result in death if left undetected and untreated. Treatment is by a special restricted protein diet and medications including phenylbutyrate to remove ammonia. Because newborn screening for these disorders is relatively new, the degree of occurrence in newborns is not yet known. (2) ASA Fact Sheet, CIT Fact Sheet
This information is not intended to replace the advice of a genetic metabolic medical professional.
Some information has been provided by STAR-G (Screening, Technology, and Research in Genetics) and GeneTests
External links to other sites are intended to be informational and do not have the endorsement of the Texas Department of State Health Services. These sites may not be accessible to persons with visual impairment.